7Baggers
Quarterly
Annual
    Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 
      
    		                               
      cash flows from operating activities
    		                               
      net income
    		-47,048,000 -37,626,000 15,826,000 -9,776,000 -54,529,000 -80,593,000 -55,460,000 -29,297,000 -37,597,000 -54,246,000 -64,398,000 -84,841,000 -118,865,000 -77,294,000 -84,448,000 -81,293,000 -77,133,000 -63,992,000 -75,801,000 -72,651,000 -64,525,000 -53,967,000 -62,563,000 -42,383,000 -37,336,000 -33,240,000 -7,281,000 -31,320,000 -31,246,000 -29,164,000 -26,374,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                               
      depreciation and amortization
    		5,677,000 5,309,000 2,171,000 2,405,000 2,349,000 4,826,000 5,682,000 4,711,000 4,173,000 4,373,000 4,198,000 4,167,000 3,958,000 3,787,000 3,682,000 3,367,000 3,371,000 3,251,000 4,662,000 3,793,000 2,858,000 2,864,000 2,959,000 3,795,000 3,706,000 2,323,000 2,458,000 1,711,000 806,000 817,000 914,000 
      stock-based compensation
    		140,400,000 132,431,000 125,042,000 125,712,000 122,423,000 120,763,000 123,811,000 115,829,000 113,312,000 103,955,000 102,136,000 99,198,000 96,554,000 83,566,000 73,742,000 68,708,000 57,705,000 50,914,000 41,269,000 39,952,000 37,525,000 30,567,000 24,738,000 19,367,000 17,662,000 14,009,000 10,553,000 10,264,000 9,078,000 7,508,000 6,169,000 
      amortization of debt discount and issuance costs
    		  0 715,000 852,000 852,000 850,000 849,000 847,000 847,000     844,000 842,000 892,000 1,427,000 12,543,000 12,360,000 12,194,000 12,023,000 5,014,000 3,335,000 3,277,000 3,221,000 3,166,000 3,139,000    
      amortization of finance right-of-use assets
    		993,000 993,000 993,000 994,000 994,000 993,000 994,000 994,000 993,000 994,000 993,000 994,000 993,000 994,000 993,000 993,000 994,000 994,000 994,000 993,000 994,000 994,000 994,000 994,000 994,000 994,000      
      amortization of operating right-of-use assets
    		2,841,000 2,758,000 2,948,000 3,229,000 2,592,000 2,479,000 2,430,000 2,302,000 2,254,000 2,225,000 2,309,000 2,331,000 2,440,000 2,018,000 1,800,000 1,778,000 1,710,000 1,522,000 1,633,000 1,893,000 1,482,000 1,372,000 960,000         
      deferred income taxes
    		-1,159,000 25,000 -15,995,000 -825,000 19,000 7,000 -1,002,000 -195,000 -189,000 -188,000 -976,000 716,000 -241,000 -61,000 132,000 -333,000 -793,000 -1,585,000 -276,000 60,000 142,000 -290,000 1,249,000 -309,000 -3,675,000 -557,000 -4,609,000 -398,000 43,000 4,000 -465,000 
      amortization of premium and accretion of discount on short-term investments
    		-2,739,000 -3,800,000 -5,942,000 -5,656,000 -5,680,000 -7,781,000 -8,151,000 -10,896,000 -12,279,000 -13,230,000                      
      realized and unrealized gain on financial instruments
    		0 272,000 253,000 -338,000                            
      unrealized foreign exchange loss
    		-759,000 1,970,000   1,089,000 115,000    429,000    581,000   729,000 315,000              
      change in operating assets and liabilities:
    		                               
      accounts receivable
    		-38,090,000 79,895,000 -57,978,000 -24,557,000 -46,027,000 59,326,000 -53,400,000 -397,000 -61,206,000 73,364,000 -53,190,000 -18,780,000 -48,220,000 28,740,000 -15,385,000 -63,215,000 -18,822,000 35,145,000 -43,476,000 -1,749,000 -6,045,000 3,637,000 -17,815,000 -1,097,000 -4,740,000 10,960,000 -28,712,000 1,238,000 -6,283,000 14,312,000 -11,248,000 
      prepaid expenses and other current assets
    		317,000 -4,973,000 -24,231,000 -1,964,000 149,000 1,233,000 -12,908,000 3,485,000 124,000 -2,909,000 -3,867,000 1,274,000 8,201,000 -3,293,000 -12,645,000 -1,371,000 3,178,000 -9,027,000 4,577,000 -1,599,000 1,612,000 234,000 -3,983,000 314,000 135,000 -260,000 -1,344,000 -2,108,000 1,336,000 -3,246,000 -475,000 
      deferred commissions
    		6,728,000 7,772,000 -30,333,000 -18,821,000 -15,153,000 -4,820,000 -24,670,000 -12,720,000 -7,104,000 2,664,000 -19,168,000 -13,354,000 -11,833,000 -4,722,000 -49,923,000 -18,363,000 -10,574,000 -5,882,000 -24,462,000 -8,168,000 -5,930,000 -3,063,000 -16,157,000 -5,159,000 -4,059,000 -2,987,000 -10,620,000 -4,194,000 -744,000 -576,000 -3,328,000 
      other long-term assets
    		1,525,000 -12,593,000 -12,973,000 -8,395,000 -9,475,000 166,000 4,000 -77,000 -92,000 -46,000 934,000 -171,000 -504,000 -358,000 524,000 -239,000 -75,000 23,000 -977,000 39,000 14,000 -170,000 95,000 -175,000 -5,000 32,000 -181,000 -79,000 116,000 -70,000 -17,000 
      accounts payable
    		1,040,000 -2,478,000 -1,028,000 1,370,000 746,000 -547,000 601,000 1,434,000 -52,000 -304,000 527,000 475,000 1,138,000 1,023,000 19,000 680,000 223,000 224,000 473,000 2,153,000 -1,629,000 219,000 665,000 -592,000 708,000 -268,000 -748,000 229,000 245,000 -639,000 -1,058,000 
      accrued liabilities
    		16,751,000 -19,353,000 2,760,000 -6,719,000 22,687,000 6,526,000 19,188,000 16,855,000 16,090,000 -12,631,000 2,580,000 -18,568,000 22,815,000 -23,016,000 25,110,000 32,671,000 18,619,000 -17,152,000 15,226,000 16,240,000 6,172,000 -2,779,000 4,263,000 7,891,000 4,961,000 3,324,000 6,380,000 5,227,000 3,924,000 -1,967,000 5,952,000 
      operating lease liabilities
    		-2,063,000 -2,688,000 -2,931,000 -3,777,000 -3,183,000 -2,185,000 -2,889,000 -2,333,000 -2,262,000 -2,394,000 -2,588,000 -2,555,000 -2,357,000 -2,192,000 -2,523,000 -1,748,000 -1,568,000 -1,027,000 -1,277,000 -2,699,000 1,088,000 -1,126,000 -1,312,000 -897,000        
      deferred revenue
    		-9,906,000 -39,624,000 54,990,000 -17,039,000 -16,882,000 -37,431,000 56,313,000 -47,374,000 -44,084,000 -47,266,000 61,786,000 23,642,000 179,000 152,000 78,743,000 48,707,000 42,000 9,749,000 42,474,000 809,000 1,607,000 3,349,000 38,156,000 2,565,000 6,066,000 6,267,000 20,163,000 7,683,000 4,334,000 4,500,000 22,266,000 
      other liabilities, non-current
    		-2,403,000 1,639,000 -78,000 92,000 -3,996,000 163,000 860,000 -3,127,000 -32,000 319,000 7,000 415,000 49,000 329,000 -1,932,000 1,583,000 277,000 3,791,000 2,110,000 1,765,000 2,439,000 451,000 38,000         
      net cash from operating activities
    		72,105,000 109,929,000 50,538,000 37,438,000 -1,398,000 63,613,000 54,627,000 38,422,000 -25,302,000 53,730,000 25,871,000 -5,744,000 -44,671,000 11,574,000 22,311,000 -5,790,000 -19,758,000 10,217,000 -18,645,000 -8,120,000 -10,030,000 -5,878,000 -8,618,000 -11,543,000 -12,593,000 3,214,000 -9,480,000 -7,608,000 -16,852,000 -8,049,000 -7,712,000 
      capex
    		146,000 -1,337,000 0 -1,981,000 -1,051,000 -539,000 -2,738,000 -2,078,000 -635,000 -623,000 -711,000 -1,381,000 -2,614,000 -2,538,000 -3,556,000 -2,184,000 -1,705,000 -627,000 -831,000 -5,646,000 -3,791,000 -1,505,000 -1,214,000 -754,000 -1,207,000 -106,000 -3,150,000 -2,137,000 -1,194,000 -367,000 -421,000 
      free cash flows
    		72,251,000 108,592,000 50,538,000 35,457,000 -2,449,000 63,074,000 51,889,000 36,344,000 -25,937,000 53,107,000 25,160,000 -7,125,000 -47,285,000 9,036,000 18,755,000 -7,974,000 -21,463,000 9,590,000 -19,476,000 -13,766,000 -13,821,000 -7,383,000 -9,832,000 -12,297,000 -13,800,000 3,108,000 -12,630,000 -9,745,000 -18,046,000 -8,416,000 -8,133,000 
      cash flows from investing activities
    		                               
      purchases of property, equipment and other assets
    		-537,000 -1,611,000                              
      business combination, net of cash acquired
    		0 -2,032,000                              
      investments in non-marketable securities
    		-3,500,000 -4,822,000 -5,500,000 -250,000                            
      proceeds from maturities of marketable securities
    		292,310,000 198,660,000 182,600,000 135,000,000 310,000,000 125,000,000 255,000,000 435,000,000 475,000,000 280,000,000 350,000,000 675,000,000 325,000,000 75,000,000 150,000,000 125,000,000 175,000,000 100,000,000 200,000,000 255,000,000 120,000,000 165,000,000 60,000,000 130,000,000 140,000,000 140,000,000 244,000,000 88,000,000 60,000,000 58,000,000 8,000,000 
      purchases of marketable securities
    		-198,668,000 -138,624,000 -442,421,000 -786,170,000 -13,029,000 -172,604,000 0 -583,252,000 -583,810,000 -66,789,000 -933,919,000 -316,433,000 -97,468,000 -100,146,000 -453,008,000 -528,264,000 -302,507,000 -101,479,000 -177,809,000 -302,568,000 -349,723,000 -160,283,000 -65,922,000 -154,505,000 -70,001,000 -139,024,000 -178,178,000 -69,269,000   -179,503,000 
      net cash from investing activities
    		89,605,000 51,571,000 -246,316,000 -653,401,000 290,420,000 -48,143,000 252,262,000 -165,330,000 -110,195,000 211,282,000 -585,005,000 355,582,000 224,918,000 -28,803,000 -308,564,000 -406,655,000 -129,412,000 -7,511,000 21,360,000 -53,714,000 -233,514,000 3,212,000 -7,136,000 -25,259,000 30,163,000 587,000 7,155,000 16,594,000 -241,661,000 57,633,000 -171,924,000 
      cash flows from financing activities
    		                               
      repurchases of common stock
    		                               
      proceeds from settlement of capped calls
    		   0                            
      proceeds from the issuance of common stock under the employee stock purchase plan
    		  17,408,000 0   17,133,000 0   13,226,000 0   12,246,000 0   9,560,000 0   7,026,000 0   4,906,000 0    
      proceeds from exercise of stock options
    		1,210,000 579,000  315,000 353,000 953,000  1,303,000 2,037,000 1,472,000  1,352,000 1,332,000 1,656,000                  
      principal payments of finance leases
    		-1,691,000 -2,394,000 -1,645,000 -895,000                            
      net cash from financing activities
    		-172,010,000 -1,815,000 15,744,000 -580,000 188,036,000 -1,140,000 17,731,000 -77,000 20,457,000 130,000 13,270,000 47,000 15,822,000 1,061,000 12,397,000 232,000 903,517,000 -25,254,000 11,579,000 6,437,000 11,855,000 -2,290,000 570,394,000 1,131,000 11,306,000 6,407,000 10,614,000 7,748,000 269,738,000 136,000 -1,311,000 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		68,000 8,000,000 -2,876,000 -274,000 -968,000 -1,583,000 665,000 -2,513,000 706,000 709,000 2,026,000 -1,634,000 -928,000 -1,467,000 -384,000 -646,000 -408,000 -94,000 646,000 665,000 546,000 -593,000 244,000 295,000        
      net increase in cash, cash equivalents and restricted cash
    		-10,232,000 167,685,000 -182,910,000 -616,817,000 476,090,000 12,747,000 325,285,000 -129,498,000 -114,334,000 265,851,000 -543,838,000 348,251,000   -274,240,000 -412,859,000   14,940,000 -54,732,000 -231,143,000 -5,549,000 554,884,000 -35,376,000 28,624,000 10,227,000      
      cash, cash equivalents and restricted cash, beginning of period
    		0 492,753,000  0 0 803,643,000  0 0 456,339,000  0 0 474,420,000  0 0 430,222,000  0 0 706,706,000  0 0 148,347,000      
      cash, cash equivalents and restricted cash, end of period
    		-10,232,000 660,438,000  -616,817,000 476,090,000 816,390,000  -129,498,000 -114,334,000 722,190,000  348,251,000 195,141,000 456,785,000  -412,859,000 753,939,000 407,580,000  -54,732,000 -231,143,000 701,157,000  -35,376,000 28,624,000 158,574,000      
      supplemental cash flow disclosure
    		                               
      cash paid during the period for:
    		                               
      income taxes, net of refunds
    		6,558,000 3,899,000 3,273,000 6,576,000 2,154,000 2,973,000  2,509,000 2,508,000 3,146,000  3,021,000 2,644,000 1,589,000  1,289,000 1,367,000 995,000  487,000 105,000 553,000    735,000      
      interest expense
    		486,000 510,000 469,000 564,000 2,073,000 599,000  638,000 2,098,000 677,000  780,000 2,170,000 755,000  785,000 2,462,000 819,000  852,000 2,651,000 884,000          
      noncash investing and financing activities:
    		                               
      issuance of common stock in connection with a business combination
    		0 141,402,000                              
      purchases of property and equipment included in accounts payable and accrued liabilities
    		683,000 274,000                        283,000      
      reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets, end of period, to the amounts shown in the statements of cash flows above:
    		                               
      cash and cash equivalents
    		-10,670,000 657,809,000 -182,921,000 -617,847,000 475,197,000 815,704,000  -129,500,000 -114,612,000 721,787,000  348,254,000 195,145,000 456,275,000  -412,856,000 753,941,000 407,055,000  -54,730,000 -231,153,000 700,645,000  -35,377,000 28,624,000 158,060,000    111,617,000  
      restricted cash, non-current
    		438,000 2,629,000 11,000 1,030,000 893,000 686,000  2,000 278,000 403,000  -3,000 -4,000 510,000  -3,000 -2,000 525,000  -2,000 10,000 512,000  1,000 0 514,000      
      total cash, cash equivalents and restricted cash
    		-10,232,000 660,438,000 -182,910,000 -616,817,000 476,090,000 816,390,000  -129,498,000 -114,334,000 722,190,000  348,251,000 195,141,000 456,785,000  -412,859,000 753,939,000 407,580,000  -54,732,000 -231,143,000 701,157,000  -35,376,000 28,624,000 158,574,000    112,139,000  
      unrealized foreign exchange gain
    		  -2,956,000     -1,621,000       1,016,000                 
      business combinations, net of cash acquired
    		                               
      proceeds from the sales of marketable securities
    		                               
      proceeds from settlement of capped calls and other
    		                               
      proceeds from exercise of stock options, including early exercised stock options
    		              2,074,000 1,846,000 2,206,000 3,539,000 3,202,000 6,747,000 4,051,000 3,000,000 3,492,000 1,933,000 4,913,000 6,437,000 4,613,000 9,525,000 7,818,000 288,000 166,000 
      cash, cash equivalents and restricted cash, beginning of year
    		                               
      cash, cash equivalents and restricted cash, end of year
    		                               
      non-cash investing and financing activities:
    		                               
      common stock issued for conversion of convertible notes
    		                               
      reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the statements of cash flows above:
    		                               
      purchases of property and equipment
    		   -1,981,000 -1,051,000 -539,000 -2,738,000 -2,078,000 -635,000 -623,000 -711,000 -1,381,000 -2,614,000 -2,538,000 -3,556,000 -2,184,000 -1,705,000 -627,000 -831,000 -5,646,000 -3,791,000 -1,505,000 -1,214,000 -754,000 -1,207,000 -389,000 -3,150,000 -2,137,000 -1,194,000 -367,000 -421,000 
      unrealized gain on financial instruments
    		     -479,000                          
      principal repayments of finance leases
    		     -2,093,000 -1,400,000 -1,380,000 -1,361,000 -1,342,000 -1,323,000 -1,305,000 -1,287,000 -595,000 -1,923,000 -1,234,000 -1,216,000 -1,199,000 -1,183,000 -1,166,000 -1,149,000 -1,135,000 -1,117,000         
      unrealized gain on non-marketable securities
    		      250,000 0 932,000 -2,226,000                      
      proceeds from issuance of common stock, net of issuance costs
    		              0 -380,000                
      repayments of convertible senior notes attributable to principal
    		              0 0 0 -27,594,000              
      investment in non-marketable securities
    		       0 -750,000 -1,306,000 -375,000 -1,604,000 0 -1,119,000 -2,000,000 -1,207,000 -200,000 -936,000 0             
      business combination
    		                               
      acquisition, net of cash acquired
    		              0 0 0 -4,469,000     0 0        
      payments of issuance costs for convertible senior notes
    		                  0 0 0 -4,154,000          
      repurchase of early exercised stock options
    		                  0 0 -10,000 -1,000 -8,000 -4,000 -1,000 -30,000 0 -18,000 -157,000 -152,000 -93,000 
      proceeds from tenant improvement allowance on build-to-suit lease
    		                          1,095,000 257,000    
      amortization of debt issuance costs
    		           845,000 845,000 840,000                  
      accretion of discount on short-term investments
    		           -1,122,000 1,845,000 2,231,000 2,562,000 1,984,000 1,467,000 1,527,000 1,077,000 604,000 -28,000 -193,000 -441,000 -868,000 -1,242,000 -1,509,000      
      gain on non-marketable securities
    		           0 57,000 -1,751,000                  
      unrealized foreign exchange (gain) loss
    		           -410,000                    
      net decrease in cash, cash equivalents and restricted cash
    		             -17,635,000    -22,642,000              
      non-cash interest on finance lease liabilities
    		                      0 0 918,000 905,000      
      loss on early extinguishment of debt
    		                               
      proceeds from borrowings on convertible senior notes, net of issuance costs
    		                           -2,016,000    
      payment for purchase of capped calls
    		                          0 0    
      proceeds from tenant improvement allowance on finance lease
    		                               
      reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets, end of period, to the amounts shown in the statements of cash flows above
    		                               
      adjustments to reconcile net income to net cash from (used) in operating activities:
    		                               
      deferred rent
    		                          384,000 341,000 445,000 472,000 -48,000 
      payments for 2024 notes partial repurchase
    		                               
      change in fair value of warrant liability
    		                              0 
      change in operating assets and liabilities, net of the impact from the acquisition:
    		                               
      proceeds from initial public offering, net of underwriting discounts and commissions
    		                               
      proceeds from exercise of redeemable convertible preferred stock warrants
    		                              0 
      payment of initial public offering costs
    		                              -1,384,000 
      construction in progress related to build-to-suit lease obligations
    		                             4,225,000  
      operating lease right-of-use assets
    		                               
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		                         19,000 53,000 -18,000 -75,000 -8,000 109,000 
      noncash investing and financing activities
    		                               
      vesting of early exercised stock options
    		                         127,000    533,000  
      reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets, end of period, to the amounts shown in the statements of cash flows above:
    		                               
      non-cash interest on office financing lease
    		                          911,000     
      proceeds from convertible senior notes, net of issuance costs
    		                               
      proceeds from issuance of series f financing, net of issuance cost
    		                               
      net increase in cash, cash equivalents, and restricted cash
    		                            11,150,000 49,712,000 -180,838,000 
      cash, cash equivalents, and restricted cash, beginning of year
    		                               
      proceeds from the ipo, net of underwriting discounts and commissions
    		                               
      cash, cash equivalents, and restricted cash, beginning of period
    		                            0 62,427,000 0 
      cash, cash equivalents, and restricted cash, end of period
    		                            11,150,000 112,139,000 -180,838,000 
      supplemental cash flow disclosure of noncash investing and financing activities
    		                               
      costs related to initial public offering included in accounts payable and accrued liabilities
    		                               
      restricted cash, current
    		                             522,000  
      proceeds from the initial public offering, net of underwriting discounts and commissions
    		                               
      supplemental disclosure of noncash investing and financing activities
    		                               
      conversion of redeemable convertible preferred stock warrant liability to redeemable convertible preferred stock as a result of warrant exercise
    		                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.